- HK$7.41bn
- HK$9.91bn
- HK$4.17bn
Brief: SSY Group Says China Approves SSY Group's Vitamin B6 Injection
Brief: SSY Group Logs 9M Net Income HKD 399 Mln
Brief: SSY Group Obtains Approval For Levamlodipine Besilate Tablets
Brief: Ssy Group Says Ambroxol Hydrochloride Approved By China's NMPA
Brief: SSY Group Gets NMPA Approval For Calcium Gluconate And Sodium Chloride Injection
Brief: SSY Group Says Indocyanine Green Approved For Registration By China's Nmpa
Brief: SSY Group Obtains NMPA Approval For Perindopril Arginine Tablets (10Mg),Others
Brief: SSY Group Obtains NMPA Approval For Production, Registration For Allopurinol Tablets
Brief: SSY Obtains Nmpa Approval For Urapidil Sustained-Release Capsules & Nicardipine Hydrochloride & Sodium Chloride Injection
Brief: SSY Group Posts HY Revenue Of HK$2.15 Bln
Brief: SSY Group Says Morinidazole Approved By China's NMPA
Brief: SSY Group Says Azilsartan Approved By China's NMPA
Brief: SSY Group Obtains Approval For Rosuvastatin Calcium And Ezetimibe Tablets From NMPA
Brief: SSY Group Obtains NMPA Approval For Eye Drops
Brief: SSY Group Ltd Says Cupric Chloride Approved By China's NMPA
Brief: SSY Group Updates On Potassium Chloride And Sodium Chloride Injection
Brief: SSY Group Got Approval For Drug Production & Registration For Paracetamol Granules
Brief: SSY Obtained Drug Production And Registration Approval For Diprophylline Injection From NMPA
Brief: SSY Group Says Caffeine Passed European Union CEP Certification